IGF-I and IGFBP2 in peripheral artery disease: results of a prospective study

References

• Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag. 2007;3:229–34.
   PubMedGoogle Scholar
• Chi YW, Jaff MR. Optimal risk factor modification and medical management of the patient with peripheral arterial disease. Catheter Cardiovasc Interv. 2008;71:475–89.
   PubMed Web of Science ®Google Scholar
• Delafontaine P, Song YH, Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol. 2004;24: 435–44.
   PubMed Web of Science ®Google Scholar
• Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation. 2002;106:939–44.
   PubMed Web of Science ®Google Scholar
• Colao A. The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol. 2008;69: 347–58.
   PubMed Web of Science ®Google Scholar
• Burgers AM, Biermasz NR, Schoones JW, Pereira AM, Renehan AG, Zwahlen M, et al. Meta-analysis and dose- response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J Clin Endocrinol Metab. 2011;96:2912–20.
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2004;89:114–20.
   PubMed Web of Science ®Google Scholar
• van Bunderen CC, van Nieuwpoort IC, van Schoor NM, Deeg DJ, Lips P, Drent ML. The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study. J Clin Endocrinol Metab. 2010;95:4616–24.
   PubMed Web of Science ®Google Scholar
• Svensson J, Carlzon D, Petzold M, Karlsson MK, Ljunggren O, Tivesten A, et al. Both low and high serum IGF-I levels associate with cancer mortality in older men. J Clin Endocrinol Metab. 2012;97:4623–30.
   PubMed Web of Science ®Google Scholar
• Arafat AM, Weickert MO, Frystyk J, Spranger J, Schofl C, Mohlig M, Pfeiffer AF. The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. J Clin Endocrinol Metab. 2009;94:5093–101.
   PubMed Web of Science ®Google Scholar
• Hu D, Pawlikowska L, Kanaya A, Hsueh WC, Colbert L, Newman AB, et al. Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study. J Am Geriatr Soc. 2009;57:1213–8.
   PubMed Web of Science ®Google Scholar
• Hassfeld S, Eichhorn C, Stehr K, Naegele H, Geier C, Steeg M, et al. Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy. Heart. 2007;93: 359–60.
   PubMed Web of Science ®Google Scholar
• Liou JM, Shun CT, Liang JT, Chiu HM, Chen MJ, Chen CC, et al. Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer. J Clin Endocrinol Metab. 2010;95: 1717–25.
   PubMed Web of Science ®Google Scholar
• Frystyk J, Dinesen B, Orskov H. Non-competitive time- resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul. 1995;5:169–76.
   PubMedGoogle Scholar
• Krassas GE, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen JW, Flyvbjerg A. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease. J Clin Endocrinol Metab. 2003;88:132–5.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72.
   PubMed Web of Science ®Google Scholar
• Friedrich N, Haring R, Nauck M, Ludemann J, Rosskopf D, Spilcke-Liss E, et al. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab. 2009;94:1732–9.
   PubMed Web of Science ®Google Scholar
• Andreassen M, Raymond I, Kistorp C, Hildebrandt P, Faber J, Kristensen LO. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur J Endocrinol. 2009;160:25–31.
   PubMed Web of Science ®Google Scholar
• Saydah S, Ballard-Barbash R, Potischman N. Association of metabolic syndrome with insulin-like growth factors among adults in the US. Cancer Causes Control. 2009;20: 1309–16.
   PubMed Web of Science ®Google Scholar
• Onder G, Liperoti R, Russo A, Soldato M, Capoluongo E, Volpato S, et al. Body mass index, free insulin-like growth factor I, and physical function among older adults: results from the ilSIRENTE study. Am J Physiol Endocrinol Metab. 2006;291:E829–34.
   PubMed Web of Science ®Google Scholar
• Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol. 1998;18: 277–82.
   PubMed Web of Science ®Google Scholar
• Probst-Hensch NM, Wang H, Goh VH, Seow A, Lee HP, Yu MC. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev. 2003;12:739–46.
   PubMed Web of Science ®Google Scholar
• Teppala S, Shankar A. Association between serum IGF-1 and diabetes among U.S. adults. Diabetes Care. 2010;33: 2257–9.
   PubMed Web of Science ®Google Scholar
• Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Growth Horm IGF Res. 2008;18:506–16.
   PubMed Web of Science ®Google Scholar
• Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev. 1999;15:314–22.
   PubMed Web of Science ®Google Scholar